Real-time enrollment status for this ductal carcinoma in situ clinical trial
Current Status
Recruiting
Checked: October 17, 2026 at 2:53 AM UTC
| NCT Number | NCT07408856 |
| Recruiting Status | Recruiting |
| Condition | Ductal Carcinoma in Situ |
| Phase | PHASE1 |
| Target Enrollment | 24 participants |
| Active Locations | 1 sites in the US |
| Sponsor | Providence Health & Services |
| Last Updated on CT.gov | September 24, 2026 (3 weeks ago) |
As of October 17, 2026: Clinical trial NCT07408856 is currently recruiting participants. This phase1 study for ductal carcinoma in situ is actively seeking new participants at 1 location across the United States. The study is sponsored by Providence Health & Services. This status information is automatically verified from the official ClinicalTrials.gov registry.
Yes, NCT07408856 is actively recruiting participants as of October 17, 2026. You can check eligibility and apply through HelloStudys.
This trial is recruiting at 1 location in the United States. View all available locations on the full study page.
Check your eligibility and express interest by completing the application form on the study page. A research coordinator will follow up to discuss next steps.
The official ClinicalTrials.gov record for NCT07408856 was last updated 3 weeks ago (September 24, 2026). HelloStudys verifies this status automatically.